Downregulation of G‑protein‑coupled receptor 30 in the hippocampus attenuates the neuroprotection of estrogen in the critical period hypothesis.

Molecular Medicine Reports
Yingxi WuTianzhi Zhao

Abstract

The aim of the present study was to investigate the role of G‑protein‑coupled receptor 30 (GPR30) in long‑term 17β‑estradiol (E2) deprivation (LTED) in a rat model with global cerebral ischemia (GCI), and its therapeutic target for ischemic stroke in the clinical setting. Following bilateral ovariectomy, GCI was induced in rats 1 or 10 weeks post‑surgery. To determine the protein and mRNA expression levels of GPR30 in the hippocampal CA1 region of LTED rats, short‑term E2 deprivation (STED) rats and naturally aging rats, western blot analysis and reverse transcription-quantitative polymerase chain reaction were performed. The results of the present study demonstrated that E2 treatment revealed significant neuroprotection post‑GCI in STED rats, but not in LTED rats, as well as a decrease in the expression levels of GPR30 in the hippocampal CA1 region. In LTED rats,. Notably, no effects were observed on the ubiquitination of GPR30 following investigation in STED or LTED rats. While the protein and mRNA expression levels of GPR30 were also decreased in the hippocampal CA1 region of female 24‑month‑old rats compared with 3‑month‑old rats. E2 treatment initiated for the entire ovariectomy period elevated GPR30 mRNA and protein expre...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
May 29, 2003·JAMA : the Journal of the American Medical Association·Sylvia Wassertheil-SmollerUNKNOWN WHI Investigators
Jun 24, 2004·JAMA : the Journal of the American Medical Association·Mark A EspelandUNKNOWN Women's Health Initiative Memory Study
Mar 8, 2006·Nature Chemical Biology·Cristian G BologaEric R Prossnitz
Aug 22, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Quan-Guang ZhangDarrell W Brann
Sep 8, 2009·Maturitas·Lynne T ShusterWalter A Rocca
Oct 22, 2009·Nature Reviews. Endocrinology·Barbara B Sherwin
Nov 6, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Quan-Guang ZhangDarrell W Brann
Jan 27, 2010·Biochimica Et Biophysica Acta·Jill M Daniel, Johannes Bohacek
Mar 23, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bing ZhangPatricia D Hurn
Jun 23, 2010·The Journal of Clinical Endocrinology and Metabolism·Richard J SantenUNKNOWN Endocrine Society
Sep 16, 2010·Annals of the New York Academy of Sciences·Michael C Craig, D G M Murphy
May 3, 2011·Current Topics in Behavioral Neurosciences·Marissa I BoulwareKaryn M Frick
Jun 8, 2011·Clinical and Experimental Pharmacology & Physiology·Shui-Bing LiuMing-Gao Zhao
Aug 17, 2011·Nature Reviews. Endocrinology·Eric R Prossnitz, Matthias Barton
Nov 15, 2011·Frontiers in Neuroendocrinology·Erin ScottDarrell Brann
Apr 12, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Shui-bing LiuMing-gao Zhao
Mar 7, 2014·Molecular and Cellular Endocrinology·Hui TangRuimin Wang

❮ Previous
Next ❯

Methods Mentioned

BETA
antisense oligodeoxynucleotide
co-immunoprecipitation
protein assay
co-IP
ubiquitination

Software Mentioned

GraphPad Prism
GraphPad
ImageJ

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.